Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Jabookie75on Apr 06, 2021 8:23pm
172 Views
Post# 32946713

RE:RE:RE:Extreme Dissapointement in Botched Launch

RE:RE:RE:Extreme Dissapointement in Botched LaunchJust listen to 35:30 of the most recent investor call after JHT drops and our Clarus analyst whispers how disappointed he is.  Disappointed in JHT dropping or disappointed in our Aristotle roll out.  Only he knows for sure.  What I know is that Clarus facilitated the last few rounds of financing and likely aren't guys you want feeling "disappointed".  The extreme volume of this sell off is telling.  I'll wait till the bleeding stops before I re-enter.  Good luck CBG.  I like your posts and you keep it real.  I've been burned too many times with this co. and simply refused to go red on my shares.  I feel fortunate to have made any profit at all.
<< Previous
Bullboard Posts
Next >>